Invenire Partners, LP Optimize Rx Corp Transaction History
Invenire Partners, LP
- $65.3 Million
- Q3 2022
A detailed history of Invenire Partners, LP transactions in Optimize Rx Corp stock. As of the latest transaction made, Invenire Partners, LP holds 105,000 shares of OPRX stock, worth $577,500. This represents 100.0% of its overall portfolio holdings.
Number of Shares
105,000Holding current value
$577,500% of portfolio
100.0%Shares
1 transactions
Others Institutions Holding OPRX
# of Institutions
98Shares Held
13.6MCall Options Held
79.8KPut Options Held
41.4K-
First Light Asset Management, LLC Edina, MN1.83MShares$10 Million1.66% of portfolio
-
Divisadero Street Capital Management, LP Miami, FL1.32MShares$7.24 Million2.27% of portfolio
-
Black Rock Inc. New York, NY1.18MShares$6.46 Million0.0% of portfolio
-
Awm Investment Company, Inc. New York, NY1MShares$5.51 Million1.54% of portfolio
-
Vanguard Group Inc Valley Forge, PA974KShares$5.35 Million0.0% of portfolio
About OptimizeRx Corp
- Ticker OPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 18,023,100
- Market Cap $99.1M
- Description
- OptimizeRx Corporation, a digital health technology company, provides various solutions to life sciences organizations, healthcare providers, and patients. The company's products and applications include financial messaging, a virtual patient support center that allows doctors and staff to access sample vouchers, co-pay coupons, and other patien...